Global Coalition for Adaptive Research in Collaboration with Cure Brain Cancer Foundation Announce the Opening of Glioblastoma Clinical Trial in Australia
GBM AGILE Adaptive Platform Trial Recruiting in Australia
Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GBM AGILE Adaptive Platform Trial Recruiting in Australia
VAL-083 did not improve efficacy compared with standard-of-care approaches in patients with glioblastoma.
LARKSPUR, Calif. & PITTSBURGH--(BUSINESS WIRE)--Oct 25, 2023--
Simvastatin, a widely available and inexpensive drug that is included on the WHO list of essential medicines, was shown to have a high probability (96%) of improving outcomes (a combination of survival and length of time patients need support in an intensive care unit) when started as a treatment for critically ill patients with COVID-19, and a 92% chance of improving survival at 3 months.
Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica